35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Melatonin protects mouse granulosa cells against oxidative damage by inhibiting FOXO1-mediated autophagy: Implication of an antioxidation-independent mechanism

      research-article
      , , , , *
      Redox Biology
      Elsevier
      Ac, acetylated, ADA, the 3 AKT phosphorylation sites of FOXO1 are mutated, AKT, thymoma viral proto-oncogene, ATG, autophagy-related, AVOs, acidic vesicular organelles, AOI, antioxidant inhibitors, BECN1, beclin 1, BP, blank plasmid, CAT, catalase, CCK-8, Cell Counting Kit-8, DBD, a FOXO1 mutant without DNA-binding activity, FOXO1N208A,H212R, EP300, E1A binding protein p300, FOXO1, forkhead box O1, GCs, granulosa cell, GPx, glutathione peroxidase, GR, glutathione reductase, GSH, glutathione, MAP1LC3B, microtubule associated protein 1 light chain 3 beta, Mel, melatonin, MTOR, mechanistic target of rapamycin (serine/threonine kinase), NPC, non-plasmid control, 3-NP, 3-nitropropionic acid, PCOS, polycystic ovary syndrome, PCD, programmed cell death, P.E, pepstatin A and E64, PIK3C3, phosphoinositide-3-kinase, class 3, PMSG, pregnant mare serum gonadotropin, PI3K, class I phosphoinositide 3-kinase, POF, premature ovarian failure, ROS, reactive oxygen species, SOD, superoxide dismutase, SQSTM1, sequestosome 1, T-AOC, total antioxidation capability, TEM, transmission electron microscopy, WCL, whole-cell lysates, 3-MA, 3-methyladenine, Melatonin, Autophagic death, FOXO1, Granulosa cells, Oxidative damage, Antioxidation-independent

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Oxidative stress has been described as a prime driver of granulosa cell (GCs) death during follicular atresia. Increasing evidence suggests potential roles of melatonin in protecting GCs from oxidative injury, though the underlying mechanisms remain largely undetermined. Here we first proposed that the inhibition of autophagy through some novel regulators contributes to melatonin-mediated GCs survival under conditions of oxidative stress. Oxidant-induced loss of GCs viability was significantly reduced after melatonin administration, which was correlated with attenuated autophagic signals upon oxidative stimulation both in vivo and in vitro. Compared with melatonin treatment, suppression of autophagy displayed similar preventive effect on GCs death during oxidative stress, but melatonin provided no additional protection in GCs pretreated with autophagy inhibitors. Notably, we found that melatonin-directed regulation of autophagic death was independent of its antioxidation/radical scavenging ability. Further investigations identified FOXO1 as a critical downstream effector of melatonin in promoting GCs survival from oxidative stress-induced autophagy. Specifically, suppression of FOXO1 via the melatonin-phosphatidylinositol 3-kinase (PI3K)-AKT axis not only improved GCs resistance to oxidative stress, but also abolished the autophagic response, from genes expression to the formation of autophagic vacuoles. Moreover, the activation of SIRT1 signaling was required for melatonin-mediated deacetylation of FOXO1 and its interaction with ATG proteins, as well as the inhibition of autophagic death in GCs suffering oxidative stress. These findings reveal a brand new mechanism of melatonin in defense against oxidative damage to GCs by repressing FOXO1, which may be a potential therapeutic target for anovulatory disorders.

          Graphical abstract

          A schematic representation of melatonin-mediated autophagy regulation in GCs during oxidative stress.

          Highlights

          • Melatonin inhibits oxidative damage in GC without scavenging oxidative stress itself.

          • Melatonin protects GC from oxidative damage via inhibiting autophagic cell death.

          • Inhibition of FOXO1-dependent autophagy by melatonin reduces oxidative damage in GC.

          • Suppression of autophagy through melatonin-PI3K-AKT-FOXO1 axis improves GC survival.

          • Melatonin reduces oxidative injury by inhibiting SIRT1-FOXO1-ATG7-dependent autophagy.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.

          Forkhead transcription factors of the FoxO subfamily are emerging as a shared component among pathways regulating diverse cellular functions, such as differentiation, metabolism, proliferation, and survival. Their transcriptional output is controlled via a two-tiered mechanism of phosphorylation and acetylation. Modest alterations of this balance can result in profound effects. The gamut of phenotypes runs from protection against diabetes and predisposition to neoplasia, conferred by FoxO loss of function, to increased cellular survival and a marked catabolic response associated with gain of function.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

            Despite the capacity of chaperones and other homeostatic components to restore folding equilibrium, cells appear poorly adapted for chronic oxidative stress that increases in cancer and in metabolic and neurodegenerative diseases. Modulation of endogenous cellular defense mechanisms represents an innovative approach to therapeutic intervention in diseases causing chronic tissue damage, such as in neurodegeneration. This article introduces the concept of hormesis and its applications to the field of neuroprotection. It is argued that the hormetic dose response provides the central underpinning of neuroprotective responses, providing a framework for explaining the common quantitative features of their dose-response relationships, their mechanistic foundations, and their relationship to the concept of biological plasticity, as well as providing a key insight for improving the accuracy of the therapeutic dose of pharmaceutical agents within the highly heterogeneous human population. This article describes in mechanistic detail how hormetic dose responses are mediated for endogenous cellular defense pathways, including sirtuin and Nrf2 and related pathways that integrate adaptive stress responses in the prevention of neurodegenerative diseases. Particular attention is given to the emerging role of nitric oxide, carbon monoxide, and hydrogen sulfide gases in hormetic-based neuroprotection and their relationship to membrane radical dynamics and mitochondrial redox signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxidative stress in COPD.

              Oxidative stress is now recognized as a major predisposing factor in the pathogenesis of COPD. Existing therapies for COPD are ineffective at halting disease progression, with bronchodilators being the mainstay of pharmacotherapy, providing symptomatic relief only. It is, therefore, important for a better understanding of the underlying mechanisms by which oxidative stress drives disease pathogenesis to develop novel and more effective therapies. Antioxidant capacity in COPD is substantially reduced as a result of cigarette smoking and exacerbations, with oxidative stress persisting long after the cessation of cigarette smoking or exacerbation, due to the continued production of reactive oxygen species from endogenous sources. We discuss (1) how oxidative stress arises in the lung, (2) how it is neutralized, (3) what genetic factors may predispose to the development of COPD, and (4) how this impacts inflammation and autoimmunity in the development of emphysema and small airways disease. Finally, various strategies have been considered to neutralize the increased oxidative burden present in COPD. This review highlights why current antioxidant strategies have so far failed and what promising alternatives are on the horizon. Moreover, a number of studies have shown that there is no single "magic bullet" to combat oxidative stress, but instead a combination therapy, targeting oxidative stress in the various subcellular compartments, may prove to be more effective in COPD.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                07 July 2018
                September 2018
                07 July 2018
                : 18
                : 138-157
                Affiliations
                [0005]College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China
                Author notes
                [* ]Correspondence to: College of Animal Science and Technology, Nanjing Agricultural University, Weigang 1, Nanjing 210095, China. liuhonglin@ 123456njau.edu.cn
                Article
                S2213-2317(18)30462-2
                10.1016/j.redox.2018.07.004
                6068202
                30014903
                ea2b7f01-6a39-4803-b1b3-1e24039fb92e
                © 2018 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 4 June 2018
                : 24 June 2018
                : 6 July 2018
                Categories
                Research Paper

                ac, acetylated,ada, the 3 akt phosphorylation sites of foxo1 are mutated,akt, thymoma viral proto-oncogene,atg, autophagy-related,avos, acidic vesicular organelles,aoi, antioxidant inhibitors,becn1, beclin 1,bp, blank plasmid,cat, catalase,cck-8, cell counting kit-8,dbd, a foxo1 mutant without dna-binding activity, foxo1n208a,h212r,ep300, e1a binding protein p300,foxo1, forkhead box o1,gcs, granulosa cell,gpx, glutathione peroxidase,gr, glutathione reductase,gsh, glutathione,map1lc3b, microtubule associated protein 1 light chain 3 beta,mel, melatonin,mtor, mechanistic target of rapamycin (serine/threonine kinase),npc, non-plasmid control,3-np, 3-nitropropionic acid,pcos, polycystic ovary syndrome,pcd, programmed cell death,p.e, pepstatin a and e64,pik3c3, phosphoinositide-3-kinase, class 3,pmsg, pregnant mare serum gonadotropin,pi3k, class i phosphoinositide 3-kinase,pof, premature ovarian failure,ros, reactive oxygen species,sod, superoxide dismutase,sqstm1, sequestosome 1,t-aoc, total antioxidation capability,tem, transmission electron microscopy,wcl, whole-cell lysates,3-ma, 3-methyladenine,melatonin,autophagic death,foxo1,granulosa cells,oxidative damage,antioxidation-independent

                Comments

                Comment on this article